Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/25 21:11 | 5/12/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | 4 | S | -3,632 | 39.59 | 0 | -92 | 656 | D | |||||||||||||||
5/9/25 19:18 | 5/7/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Lamy Patrick | CA | O | SVP,Comm | 2 | S.d | -388 | 43.12 | 0 | -9 | 33 | D | |||||||||||||||
5/8/25 19:34 | 5/6/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Rolph Timothy | CA | O | Chief Sc | 5 | S.d | -1,603 | 42.17 | 0 | -38 | 170 | D | |||||||||||||||
4/16/25 18:00 | 4/15/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Yale Catriona | CA | O | Chief De | 4 | S.d | -1,318 | 44.39 | 0 | -30 | 96 | D | |||||||||||||||
3/14/25 20:33 | 3/12/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | 2 | S | -2,270 | 44.86 | 0 | -51 | 261 | D | |||||||||||||||
3/14/25 20:24 | 3/12/25 | AKRO | Health | Drug | Pharmaceutical Preparations | White William Richard | CA | O | CFO | 1 | S | -30 | 44.88 | 0 | -1 | 62 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |